October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Videos|December 24, 2014
What 1 Pharmacist has Learned from Using Sedation for Pain and Delirium in Critically Ill Patients
John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what he's learned from using sedation for pain and delirium in critically ill patients.
Advertisement
John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what he's learned from using sedation for pain and delirium in critically ill patients.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Advertisement
Related to this article
Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association, discusses pharmacists’ role in diabetes and CKD care at ASN Kidney Week 2026.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
At the 2026 ASTCT Gene Therapy Summit, experts highlighted how chronic pain, psychological challenges, and neurologic complications may persist despite successful treatment.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
2
Community Pharmacists Guide Patients New to Glucose Monitoring
3
FDA Approves Tildrakizumab for Adults With Psoriatic Arthritis
4
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
5